AppFolio (APPF) Reaches $44.40 After 6.00% Down Move; Acceleron Pharma (XLRN) Covered By 10 Bulls

September 13, 2017 - By Peter Kolinski

Among 14 analysts covering Acceleron Pharma (NASDAQ:XLRN), 10 have Buy rating, 1 Sell and 3 Hold. Therefore 71% are positive. Acceleron Pharma had 27 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Acceleron Pharma Inc (NASDAQ:XLRN) has “Buy” rating given on Tuesday, September 12 by UBS. Citigroup initiated Acceleron Pharma Inc (NASDAQ:XLRN) on Thursday, September 29 with “Neutral” rating. As per Tuesday, December 13, the company rating was initiated by Oppenheimer. The company was maintained on Monday, June 13 by Barclays Capital. Oppenheimer initiated the stock with “Outperform” rating in Friday, November 20 report. On Friday, June 23 the stock rating was maintained by FBR Capital with “Buy”. The firm has “Outperform” rating by FBR Capital given on Friday, January 15. The rating was maintained by FBR Capital on Tuesday, June 13 with “Buy”. Oppenheimer reinitiated the stock with “Outperform” rating in Monday, February 1 report. The stock of Acceleron Pharma Inc (NASDAQ:XLRN) has “Overweight” rating given on Wednesday, April 27 by Barclays Capital. See Acceleron Pharma Inc (NASDAQ:XLRN) latest ratings:

12/09/2017 Broker: UBS Rating: Buy New Target: $50.0 Maintain
04/08/2017 Broker: Credit Suisse Rating: Buy New Target: $35.0000
04/08/2017 Broker: Citigroup Rating: Buy New Target: $44.0000
01/08/2017 Broker: Oppenheimer Rating: Hold Maintain
23/06/2017 Broker: FBR Capital Rating: Buy Maintain
26/06/2017 Broker: Piper Jaffray Rating: Buy New Target: $40.0000
23/06/2017 Broker: Oppenheimer Rating: Hold Maintain
13/06/2017 Broker: JMP Securities Rating: Buy New Target: $34.0000
13/06/2017 Broker: FBR Capital Rating: Buy New Target: $63.0000 Maintain
13/06/2017 Broker: Leerink Swann Rating: Buy New Target: $36.0000

The stock of AppFolio Inc (NASDAQ:APPF) is a huge mover today! About 57,296 shares traded. AppFolio Inc (NASDAQ:APPF) has risen 112.92% since September 13, 2016 and is uptrending. It has outperformed by 96.22% the S&P500.The move comes after 6 months negative chart setup for the $1.51 billion company. It was reported on Sep, 13 by Barchart.com. We have $41.74 PT which if reached, will make NASDAQ:APPF worth $90.60M less.

Among 5 analysts covering AppFolio Inc (NASDAQ:APPF), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. AppFolio Inc had 11 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, May 13. The company was initiated on Tuesday, July 21 by Credit Suisse. William Blair initiated the stock with “Outperform” rating in Tuesday, July 21 report. The stock of AppFolio Inc (NASDAQ:APPF) earned “Sector Weight” rating by Pacific Crest on Tuesday, July 21. The stock of AppFolio Inc (NASDAQ:APPF) has “Equal-Weight” rating given on Tuesday, August 8 by Morgan Stanley. The company was maintained on Tuesday, February 23 by Credit Suisse. On Tuesday, August 8 the stock rating was maintained by Credit Suisse with “Hold”. The firm has “Buy” rating by KeyBanc Capital Markets given on Friday, August 11. Morgan Stanley initiated it with “Overweight” rating and $22 target in Tuesday, July 21 report. Morgan Stanley maintained the shares of APPF in report on Thursday, July 20 with “Equal-Weight” rating.

AppFolio, Inc. is a provider of industry-specific, cloud software solutions for small and medium-sized businesses in the property management and legal industries. The company has market cap of $1.51 billion. The Company’s mobile-optimized software solutions enable its clients to work at any time and from anywhere across multiple devices. It has a 1627.58 P/E ratio. The Company’s property management software provides small and medium-sized property managers with an end-to-end solution to their business needs.

About 267,005 shares traded. Acceleron Pharma Inc (NASDAQ:XLRN) has declined 22.43% since September 13, 2016 and is downtrending. It has underperformed by 39.13% the S&P500.

Investors sentiment increased to 1.44 in 2016 Q4. Its up 0.51, from 0.93 in 2016Q3. It increased, as 21 investors sold Acceleron Pharma Inc shares while 34 reduced holdings. 25 funds opened positions while 49 raised stakes. 31.42 million shares or 3.11% more from 30.48 million shares in 2016Q3 were reported. Creative Planning holds 2,650 shares. Moreover, Proshare Advsrs Lc has 0.01% invested in Acceleron Pharma Inc (NASDAQ:XLRN) for 29,339 shares. Highbridge Mgmt accumulated 18,092 shares. California State Teachers Retirement has invested 0% of its portfolio in Acceleron Pharma Inc (NASDAQ:XLRN). Susquehanna Intll Llp reported 27,601 shares stake. Artal Grp holds 150,000 shares or 0.08% of its portfolio. Blackrock Advsrs Limited Co owns 0.02% invested in Acceleron Pharma Inc (NASDAQ:XLRN) for 889,177 shares. Moreover, Sectoral Asset Management has 0.98% invested in Acceleron Pharma Inc (NASDAQ:XLRN). 15,000 were reported by Weiss Multi. Legal General Gru Public Ltd Liability Company holds 9,653 shares. Hamilton Lane Ltd Company reported 92,990 shares or 1.56% of all its holdings. Evercore Wealth Mgmt Lc invested 0.03% of its portfolio in Acceleron Pharma Inc (NASDAQ:XLRN). Jennison Assocs Limited Liability Com accumulated 0% or 30,041 shares. Alpinvest Prtnrs Bv, a Netherlands-based fund reported 23,272 shares. Perceptive Lc has 619,987 shares for 1.13% of their portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>